Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › (3,4-disubstituted)propanoic carboxylates as S1P (Edg) receptor agonists

(3,4-disubstituted)propanoic carboxylates as S1P (Edg) receptor agonists

US Patent 7605171 · Granted Oct 20, 2009

Estimated economic value: $116,613,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Glucose-responsive insulin conjugates2025
1,3,4,7-tetrahydro-2H-pyrrolo[3′,2′:5,6]pyrido[2,3-b][1,4]oxazepine bcl-2 inhibi2024
Apoptosis inducing agents for the treatment of cancer and immune and autoimmune 2024
Conjugate based systems for controlled insulin delivery2023
Conjugate based systems for controlled insulin delivery2023
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune 2023
Anti-c-Met antibody drug conjugates2023
Bisaryl amides as NRF2 activators2021
Insulin dimer-incretin conjugates2021
Insulin dimer-incretin conjugates2021
Glucose responsive insulin comprising a tri-valent sugar cluster for treatment o2021
Glucose responsive insulin comprising a tri-valent sugar cluster for treatment o2021